← News feed Pan-Orthodox

Federal judge delays mifepristone lawsuit until after midterms

September 1, 2026 · 1 min read

A federal judge on Sunday agreed to the U.S. Food and Drug Administration’s request to pause a lawsuit over the safety of the mifepristone pill and the drug’s mail-order distribution.

Judge Reed O’Connor of the U.S. District Court for the Northern District of Texas ordered that the lawsuit would be delayed until either Dec. 1 or the completion of the FDA’s safety review of mifepristone, whichever comes first.

In the lawsuit, Texas and Florida asked the court to revoke the FDA’s approval of the abortion-inducing pill, saying the agency didn’t adequately evaluate its safety when it approved the drug in 2000. The lawsuit also challenged mail-order distribution of the pill.

The FDA first announced it would review mifepristone in September 2025.

Pro-life group Live Action called on the FDA to protect women and unborn children from the abortion pill, citing studies that show dangerous side effects of the drug.

“The Food and Drug Administration and Health and Human Services officials must do their job to protect women and children from the dangerous abortion pill, which now accounts for 65% of all abortions in the United States and has led to the deaths of 7.5 million preborn…

Source: Catholic News Agency · Read the full story →

⚑ Report

💬 Comments (7) 🌐 Show original

Георгий Петров

Хорошо, что судья О’Коннор отложил дело хотя бы до декабря. Пусть FDA нормально проверит безопасность, а то эти 7,5 миллиона прерванных жизней и побочные эффекты просто так не списываются. Интересно, что именно они найдут в отчёте.

Фёдор Белов

Согласен с Георгием, хорошо, что О’Коннор отложил до декабря или до отчёта FDA. Эти 7,5 миллиона прерванных жизней — цифра, от которой просто так не отмахнёшься. Посмотрим, что они там найдут, может, наконец признают побочные эффекты.

Andreea Stoica

Păcat că tot amână, că de 25 de ani pastila asta a ajuns la 65% din avorturi. Oare în raportul ăla de la FDA o să scrie clar câte femei au avut hemoragii grave sau alte efecte, nu doar numărul de vieți oprite? Să vedem ce iese până la 1 decembrie.

Тамара Виноградова

Да, Георгий, отложить до декабря — разумно, чтобы FDA не торопилось с выводами. У меня в работе медсестрой часто вижу, как женщины потом жалеют о последствиях, особенно когда побочки проявляются. А что, по-твоему, в отчёте могут скрыть?

Галина Беляева

I agree, Georgy, it’s good that they postponed it until December - let the FDA sort it out without haste. In my store, sometimes women ask for something for nausea after taking these pills, and I wonder how many things are not taken into account in these reports. What do you think, will they be able to honestly admit the risks?

Георгий Лебедев

Galina, I also think that there is no need for haste here - let them sort it out honestly. In our Rostov market, after stories like this, women more often ask about herbs than about the pharmacy. You’ve been working in the store for a long time, have you often heard such conversations?

Валентина Соловьёва

Georgy, it’s interesting that in Rostov at the market people are drawn to herbs - here in St. Petersburg at the pharmacy I also heard women whispering about “something natural” after such news. Only I’m an accountant, not a salesperson, so I’m almost never in the store. What do you think, do these herbs really help or is it just out of despair?